SHZ · 301580.SZ
Aidite Qinhuangdao Technology Co Ltd
CN¥40.63+CN¥0.66 (+1.65%)
Aidite Qinhuangdao Technology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.23% below the high.
Loading market information…
SHZ · 300453.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Jiangxi Sanxin Medtec Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.54% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jiangxi Sanxin Medtec Co.,Ltd.’s forward annual dividend is CN¥0.20 per share, paid semi-annual. The forward yield is 2.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Jiangxi Sanxin Medtec Co.,Ltd.’s next earnings report is currently expected on Mar 22, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jiangxi Sanxin Medtec Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Nanchang, China, in 1997, Jiangxi Sanxin Medtec Co., Ltd. is a medical technology company dedicated to the research, development, manufacturing, sales, and servicing of medical devices. The company operates both domestically and internationally, offering a wide array of products across several key therapeutic categories: Renal Dialysis and Blood Purification: This segment includes advanced centralized dialysate supply systems, hemodialysis water preparation units, and hemodialysis machines. It also provides a variety of consumables such as specialized nursing kits, central venous catheter packs, arteriovenous spikes, HDF accessory tubing, dialysate filters, hemodialysis powders and concentrates, hollow fiber hemodialyzers, sterile blood circuits, and tubing sets for hemodialysis. Infusion and Transfusion Equipment: The company supplies various infusion and transfusion sets, including light-resistant, TPE precise filter, and auto-stop fluid precise filter types, alongside standard transfusion sets, catheter infusion sets, and precise filter light-resistant options. Injection Devices: Its portfolio encompasses diverse syringes, such as insulin, dispenser, sterile, auto-disable, and fixed-dose immunization syringes. This category also features hypodermic needles, innovative needleless injection systems, and pneumatic syringes. Intravenous Catheterization Products: Offerings include various indwelling catheters like straight, Y-type, and closed IV catheters, positive pressure IV catheters, central venous catheter kits, extension tubes with three-way valves, and heparin caps. General Medical Supplies: Additional products include blood microembolus filters, disposable extracorporeal circulation tubing kits, cold cardioplegic solution perfusion apparatus, blood containers, medical-grade surgical masks, disinfectants, and alcohol pads.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥40.63+CN¥0.66 (+1.65%)
Aidite Qinhuangdao Technology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.23% below the high.
CN¥5.45+CN¥0.01 (+0.18%)
Blue Sail Medical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.83% below the high.
CN¥7.18+CN¥0.08 (+1.13%)
Yabao Pharmaceutical Group Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 3.62% below the high.
CN¥7.41+CN¥0.04 (+0.54%)
ZJAMP Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.48% below the high.
CN¥17.39-CN¥0.15 (-0.86%)
Zhejiang Gongdong Medical Technology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.32% below the high.
CN¥6.89-CN¥0.17 (-2.41%)
Chimin Health Management Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.26% below the high.
CN¥8.30-CN¥0.07 (-0.84%)
Tibet Weixinkang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.22% below the high.
CN¥43.66-CN¥0.30 (-0.68%)
Hangzhou Alltest Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.09% below the high.
